Neurodevelopmental Disorders and L-carnosine: A Clinical Perspective

Neurodevelopmental disorders (NDDs) affect approximately 15% of children and adolescents worldwide.Neurodevelopmental disorders, including attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), pose significant challenges in diagnosis, care, and treatment.L-carnosine, a naturally occurring dipeptide with antioxidant and neuroprotective properties, has shown therapeutic potential in managing NDDs.The complex interplay of genetic, environmental, and epigenetic factors in NDDs necessitates a comprehensive treatment approach.L-carnosine, a naturally occurring dipeptide with antioxidant, anti-inflammatory, and neuroprotective properties, has shown therapeutic potential in managing NDDs.Clinical studies have demonstrated that L-carnosine supplementation can improve behavioral symptoms, cognitive function, and social communication in children with ADHD and ASD.This review explores the potential therapeutic effects of L-carnosine on NDDs and implications for clinical practice.The findings suggest that L-carnosine could be a valuable complementary treatment option in the comprehensive management of NDDs, offering a promising avenue for improving the lives of affected individuals.